Roche Group

genentech, united states, is a wholly owned member of the roche group.

美国的基因技术公司是罗氏集团的拥有成员。

In August Pascal Soriot, vet-turned-Roche executive, was named the new boss at AstraZeneca, even though the pharmaceutical group had an obvious internal candidate in Simon Louth, chief financial officer and interim chief executive.

去年8月份，兽医出身的罗氏（Roche）高管帕斯卡尔•索略特（Pascal Soriot）被任命为阿斯利康（AstraZeneca）的新任首席执行官，尽管这家制药集团拥有一位明显的内部候选人——首席财务官及代理CEO西蒙•劳斯（Simon Louth）。